MedPath

Effect of Gandha Taila Nasya (medicine administered through nasal route) in the management of Vishwachi (cervical spondylosis) and comparing its effect with Tila Taila Nasya (medicine administered through nasal route)

Phase 2
Conditions
Health Condition 1: M479- Spondylosis, unspecified
Registration Number
CTRI/2023/10/059210
Lead Sponsor
Dr MAMATHA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

pain radiating from upper limb to fingers

Associated with any of the following symptoms

1. weakness

2. stiffness

3. tingling sensation

4. Pain in cervical region

5. Positive Spurling test

patients who are fit for nasal drug administration

Exclusion Criteria

1. Congenital condition of cervical spine.

2. Patients with the history of trauma of cervical spine.

3. Contraindicated for nasal drug administration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath